Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation

doi:10.5500/wjt.v6.i3.583

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7906)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

578

WORD

277

HTML

4037

Figures (1-1)

276

Tables (1-3)

191

Sum=5359

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1027

Download

1520

Sum=2547

Sep 24, 2016 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Transplant. Sep 24, 2016; 6(3): 583-593
Published online Sep 24, 2016. doi: 10.5500/wjt.v6.i3.583

Table 1 Demographic and laboratory data of the Patient Population and their indication for liver transplantation

	Study group (n = 261)
Males/females (n/n), %	(193/68) 73.9%/26.1%
Age (yr)	53.5 ± 9.4
Body mass index (kg/m²)	26.18 ± 6.40
MELD score	24 ± 6.5
Indication for liver transplantation (n, %)
Alcoholism	40 (15.3 %)
Viral	189 (72.4%)
Colestatic	15 (5.7%)
Other	17 (6.5 %)
HCC	107 (41 %)
Laboratory data
Hb (g/dL)	11.3 ± 2.2 (nv:12-16)
Hct (%)	3.4 ± 6.2 (nv: 36-46)
PLT (10³/μL)	83.2 ± 66.7 (nv: 150-450)
PT (%)	53.6 ± 22.4 (nv: 70-100)
INR	1.7 ± 0.7 (nv: 0.84-1.24)
aPTT ratio	2.0 ± 9.3 (nv: 0.82-1.24)
Fibrinogen (mg/dL)	190 ± 120 (nv: 200-400)
ATIII (%)	50 ± 27(nv: 80-120)

Data are expressed as the median ± SD. MELD: Model for end stage liver disease; HCC: Hepatocellular carcinoma; PLT: Platelets; PT: Prothrombin time; INR: International normalized ratio; nv: Normal values.

Citation: De Pietri L, Bianchini M, Rompianesi G, Bertellini E, Begliomini B. Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation. World J Transplant 2016; 6(3): 583-593
URL: https://www.wjgnet.com/2220-3230/full/v6/i3/583.htm
DOI: https://dx.doi.org/10.5500/wjt.v6.i3.583